Search research articles
Contact Us
Filters
Showing results (111-120 of 359) with videos related to
Page
of 36
Sort By:
Annals of Internal Medicine
|
December 15, 1991
High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma
M A Dimopoulos, B Barlogie, T L Smith, et al.
Cancer Research
|
June 1, 1983
Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro
B Drewinko, L Y Yang, B Barlogie, et al.
Cancer Research
|
April 1, 1981
Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidine
L Teodori, B Barlogie, B Drewinko, et al.
Cancer Research
|
September 1, 1981
Biological properties of the human colonic adenocarcinoma cell line SW 620 grown as a xenograft in the athymic mouse
J J Stragand, B Barlogie, R A White, et al.
Cell and Tissue Kinetics
|
September 1, 1984
Cultured human tumour cells may be arrested in all stages of the cycle during stationary phase: demonstration of quiescent cells in G1, S and G2 phase
B Drewinko, L Y Yang, B Barlogie, et al.
Seminars in Oncology
|
October 21, 1999
Novel approaches in myeloma therapy
N C Munshi, B Barlogie, K R Desikan, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1984
High-dose cytosine arabinoside in multiple myeloma
H Kantarjian, R Dreicer, B Barlogie, et al.
Critical Reviews in Oncology/Hematology
|
March 14, 2003
Angiogenesis in hematologic malignancies
T M Moehler, A D Ho, H Goldschmidt, et al.
Cancer Research
|
July 1, 1976
Kinetic response of human lymphoid cells to adriamycin-DNA complex in vitro
B Barlogie, B Drewinko, R S Benjamin, et al.
The Journal of Clinical Investigation
|
August 1, 1985
Cytoplasmic immunoglobulin content in multiple myeloma
B Barlogie, R Alexanian, M Pershouse, et al.
Page
of 36
Search research articles
Search
Showing results (111-120 of 359) with videos related to
Sort By:
Page
of 36
Annals of Internal Medicine
|
December 15, 1991
High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma
M A Dimopoulos, B Barlogie, T L Smith, et al.
Cancer Research
|
June 1, 1983
Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitro
B Drewinko, L Y Yang, B Barlogie, et al.
Cancer Research
|
April 1, 1981
Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidine
L Teodori, B Barlogie, B Drewinko, et al.
Cancer Research
|
September 1, 1981
Biological properties of the human colonic adenocarcinoma cell line SW 620 grown as a xenograft in the athymic mouse
J J Stragand, B Barlogie, R A White, et al.
Cell and Tissue Kinetics
|
September 1, 1984
Cultured human tumour cells may be arrested in all stages of the cycle during stationary phase: demonstration of quiescent cells in G1, S and G2 phase
B Drewinko, L Y Yang, B Barlogie, et al.
Seminars in Oncology
|
October 21, 1999
Novel approaches in myeloma therapy
N C Munshi, B Barlogie, K R Desikan, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1984
High-dose cytosine arabinoside in multiple myeloma
H Kantarjian, R Dreicer, B Barlogie, et al.
Critical Reviews in Oncology/Hematology
|
March 14, 2003
Angiogenesis in hematologic malignancies
T M Moehler, A D Ho, H Goldschmidt, et al.
Cancer Research
|
July 1, 1976
Kinetic response of human lymphoid cells to adriamycin-DNA complex in vitro
B Barlogie, B Drewinko, R S Benjamin, et al.
The Journal of Clinical Investigation
|
August 1, 1985
Cytoplasmic immunoglobulin content in multiple myeloma
B Barlogie, R Alexanian, M Pershouse, et al.
Page
of 36